SkyePharma PLC Receives Corporate Rating from N+1 Singer (SKP)
SkyePharma PLC (LON:SKP)‘s stock had its “corporate” rating restated by investment analysts at N+1 Singer in a note issued to investors on Thursday, ARN reports.
SkyePharma PLC (LON:SKP) traded down 1.77% during mid-day trading on Thursday, hitting GBX 111.00. 60,344 shares of the company’s stock traded hands. SkyePharma PLC has a one year low of GBX 39.00 and a one year high of GBX 123.00. The stock’s 50-day moving average is GBX 113.3 and its 200-day moving average is GBX 95.55. The company’s market cap is £51.2 million.
SkyePharma PLC is a speciality drug delivery company developing oral and inhalation products. The principal activities of the Company included the research and development, manufacture and sale of prescription pharmaceutical products.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.